Ignite Creation Date:
2024-05-06 @ 2:52 PM
Last Modification Date:
2024-10-26 @ 1:39 PM
Study NCT ID:
NCT04458259
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-03
First Post:
2020-06-24
Brief Title:
Study of PF-07265807 in Participants With Metastatic Solid Tumors
Sponsor:
Pfizer
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neoplasm Metastasis |
Keywords:
| Name | View |
|---|---|
| Colorectal cancer CRC | View |
| TAMK TAM kinase | View |
| MER mer proto-oncogene | View |
| MERTK mer proto-oncogene tyrosine kinase | View |
| AXL AXL receptor tyrosine kinase | View |
| AXLMER | View |
| Selective kinase inhibitor | View |
| PD-1 programmed cell death protein 1 | View |
| PD-L1 programmed cell death ligand 1 | View |
| Immune modulator | View |
| Advanced Cancer | View |
| Metastatic Cancer | View |
| Solid Tumor Cancer | View |
| Metastatic Solid Tumor | View |
| Cervical Cancer | View |
| Gastric Cancer | View |
| Esophageal Cancer | View |
| Endometrial Cancer | View |
| Hepatocellular carcinoma HCC | View |
| Melanoma | View |
| Merkel Cell Carcinoma | View |
| High levels of MicroSatellite Instability deficient MisMatch Repair MSI-H-dMMR tumor | View |
| Non-small cell lung cancer NSCLC | View |
| Small cell lung cancer SCLC | View |
| Renal cell carcinoma RCC | View |
| Urothelial carcinoma | View |